| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.58B | $2.24B | $1.95B |
| YoY Revenue Growth % | +15.5% | +15.0% | — |
| Gross Profit | $1.92B | $1.71B | — |
| Gross Margin % | 74.1% | 76.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$34.0M | -$197.0M | -$270.0M |
| Operating Margin % | -1.3% | -8.8% | -13.9% |
| Net Income (GAAP) | $23.0M | -$112.0M | -$158.0M |
| EBITDA (Normalized) | $72.4M | -$82.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $368.0M | $428.0M | $354.0M |
| Capital Expenditures (CapEx) | $133.0M | $143.0M | — |
| Free Cash Flow (FCF) | $235.0M | $285.0M | $354.0M |
| FCF Margin % | 9.1% | 12.7% | 18.2% |
| Return on Invested Capital (ROIC %) | -0.7% | -4.1% | — |
| Cash & Short-Term Equivalents | $768.0M | $1.08B | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $4.88B | $4.85B | — |